癌におけるAI

世界の癌におけるAIの市場規模は、2024年の22億米ドルから、予測期間中に23.1%のCAGRで推移し、2029年には63億米ドルの規模に達すると予測されています。

北米市場は、2024年の9億9,560万米ドルから、21.6%のCAGRで推移し、2029年には27億米ドルに達すると予測されています。アジア太平洋市場は、2024年の4億7,650万米ドルから、26.2%のCAGRで推移し、2029年には15億米ドルに達すると予測されています。

当レポートでは、世界の癌におけるAIの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場分析

第2章 市場概要

• 概要
• 癌におけるAIの現在の応用と今後の応用
• 診断
• 治療
• スクリーニングと早期発見
• 医薬品の発見と開発

第3章 市場力学

• 市場力学スナップショット
• 市場促進要因
• 医薬品の発見と開発におけるAI
• 癌の発生率増加
• 市場抑制要因
• データ収集とプライバシー
• 誤検知とバイアス
• 市場機会
• AI対応ハードウェア製品

第4章 新興技術

• 多発癌性疾患の早期発見のためのAI
• セラノスティクスとAI
• 生成AIツール
• フェデレーテッドラーニング

第5章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場分析：癌タイプ別
• 乳癌
• 肺癌
• 前立腺癌
• 消化器癌
• 脳腫瘍
• その他
• 市場分析：用途別
• 診断
• 医薬品の発見と開発
• 治療
• 癌検診
• その他
• 市場分析：エンドユーザー別
• 市場規模・予測
• 病院
• 診断センター
• 製薬会社
• 調査機関
• 地理的内訳
• 市場分析：地域別
• 市場規模・予測
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 概要
• パートナーシップ
• M&A活動
• 投資と資金調達
• 特許分析

第7章 癌におけるAI：持続可能性

• 癌におけるAI：持続可能性
• ESGデータの理解
• 環境パフォーマンス
• 社会的パフォーマンス
• ガバナンスパフォーマンス
• BCCからの総論

第8章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• AZRA AI
• CONCERTAI
• GE HEALTHCARE
• ICAD INC.
• LUNIT INC.
• MEDIAN TECHNOLOGIES
• NVIDIA CORP.
• QUEST DIAGNOSTICS INC.
• SIEMENS HEALTHINEERS AG

List of Tables

• Summary Table : Global Market for AI in Cancer, by Region, Through 2029
• Table 1 : Incidence and Mortality Rates of Cancer Across Regions, 2022
• Table 2 : Global Market for AI in Cancer, by Cancer Type, Through 2029
• Table 3 : Select List of AI-Based Tools for Breast Cancer
• Table 4 : Global Market for AI in Breast Cancer, by Region, Through 2029
• Table 5 : Select List of AI-Based Tools for Lung Cancer
• Table 6 : Global Market for AI in Lung Cancer, by Region, Through 2029
• Table 7 : Select List of AI-Based Tools for Prostate Cancer
• Table 8 : Global Market for AI in Prostate Cancer, by Region, Through 2029
• Table 9 : Select List of AI-Based Tools for Gastrointestinal Cancers
• Table 10 : Global Market for AI in Gastrointestinal Cancers, by Region, Through 2029
• Table 11 : Global Market for AI in Brain Cancer, by Region, Through 2029
• Table 12 : Global Market for AI in Other Cancer Types, by Region, Through 2029
• Table 13 : Global Market for AI in Cancer, by Application, Through 2029
• Table 14 : Global Market for AI in Cancer Diagnosis, by Region, Through 2029
• Table 15 : Select Companies Using AI for Drug Discovery
• Table 16 : Global Market for AI in Cancer Drug Discovery and Development, by Region, Through 2029
• Table 17 : Global Market for AI in Cancer Therapy, by Region, Through 2029
• Table 18 : Global Market for AI in Cancer Screening, by Region, Through 2029
• Table 19 : Global Market for AI in Other Applications, by Region, Through 2029
• Table 20 : Global Market for AI in Cancer, by End User, Through 2029
• Table 21 : Global Market for AI in Cancer for Hospitals, by Region, Through 2029
• Table 22 : Global Market for AI in Cancer for Diagnostic Centers, by Region, Through 2029
• Table 23 : Global Market for AI in Cancer for Pharmaceutical Companies, by Region, Through 2029
• Table 24 : Global Market for AI in Cancer for Research Institutions, by Region, Through 2029
• Table 25 : Global Market for AI in Cancer, by Region, Through 2029
• Table 26 : North American Market for AI in Cancer, by Country, Through 2029
• Table 27 : North American Market for AI in Cancer, by Cancer Type, Through 2029
• Table 28 : North American Market for AI in Cancer, by Application, Through 2029
• Table 29 : North American Market for AI in Cancer, by End User, Through 2029
• Table 30 : European Market for AI in Cancer, by Country, Through 2029
• Table 31 : European Market for AI in Cancer, by Cancer Type, Through 2029
• Table 32 : European Market for AI in Cancer, by Application, Through 2029
• Table 33 : European Market for AI in Cancer, by End User, Through 2029
• Table 34 : Asia-Pacific Market for AI in Cancer, by Country, Through 2029
• Table 35 : Asia-Pacific Market for AI in Cancer, by Cancer Type, Through 2029
• Table 36 : Asia-Pacific Market for AI in Cancer, by Application, Through 2029
• Table 37 : Asia-Pacific Market for AI in Cancer, by End User, Through 2029
• Table 38 : Select Chinese Companies Using AI for Cancer
• Table 39 : RoW Market for AI in Cancer, by Cancer Type, Through 2029
• Table 40 : RoW Market for AI in Cancer, by Application, Through 2029
• Table 41 : RoW Market for AI in Cancer, by End User, Through 2029
• Table 42 : Select Strategic Alliances in the AI in Cancer Industry, 2022-2024
• Table 43 : AI in the Cancer Industry: Select M&A Activities, 2022-2024
• Table 44 : Major Funding Activities of AI in the Cancer Industry, 2022-2024
• Table 45 : Select Active Patents of the Key Competitor Companies, 2024
• Table 46 : ESG Rankings for Major Cancer AI Companies, 2024*
• Table 47 : ESG: Environmental Overview
• Table 48 : ESG: Social Overview
• Table 49 : ESG: Governance Overview
• Table 50 : Report Sources
• Table 51 : Glossary of Terms Used in the AI in the Cancer Market
• Table 52 : Azra AI: Company Snapshot
• Table 53 : Azra AI: Product Portfolio
• Table 54 : Azra AI: News/Key Developments, 2023 and 2024
• Table 55 : ConcertAI: Company Snapshot
• Table 56 : ConcertAI: Product Portfolio
• Table 57 : ConcertAI: News/Key Developments, 2022-2024
• Table 58 : GE HealthCare: Company Snapshot
• Table 59 : GE HealthCare: Financial Performance, FY 2022 and 2023
• Table 60 : GE HealthCare: Product Portfolio
• Table 61 : GE HealthCare: News/Key Developments, 2024
• Table 62 : iCAD Inc.: Company Snapshot
• Table 63 : iCAD Inc.: Financial Performance, FY 2022 and 2023
• Table 64 : iCAD Inc.: Product Portfolio
• Table 65 : iCAD Inc.: News/Key Developments, 2024
• Table 66 : Lunit Inc.: Company Snapshot
• Table 67 : Lunit Inc.: Financial Performance, FY 2022 and 2023
• Table 68 : Lunit Inc.: Product Portfolio
• Table 69 : Lunit Inc.: News/Key Developments, 2023 and 2024
• Table 70 : Median Technologies: Company Snapshot
• Table 71 : Median Technologies: Financial Performance, FY 2022 and 2023
• Table 72 : Median Technologies: Product Portfolio
• Table 73 : Median Technologies: News/Key Developments, 2023
• Table 74 : NVIDIA Corp.: Company Snapshot
• Table 75 : NVIDIA Corp.: Financial Performance, FY 2022 and 2023
• Table 76 : NVIDIA Corp.: Product Portfolio
• Table 77 : NVIDIA Corp.: News/Key Developments, 2022
• Table 78 : Quest Diagnostics Inc.: Company Snapshot
• Table 79 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
• Table 80 : Quest Diagnostics Inc.: Product Portfolio
• Table 81 : Quest Diagnostics Inc.: News/Key Developments, 2024
• Table 82 : Siemens Healthineers AG: Company Snapshot
• Table 83 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
• Table 84 : Siemens Healthineers AG: Product Portfolio
• Table 85 : Siemens Healthineers AG: News/Key Developments, 2024

List of Figures

• Summary Figure : Global Market Shares of AI in Cancer, by Region, 2023
• Figure 1 : Applications of AI in Cancer Care
• Figure 2 : Role of AI in Cancer Drug Discovery and Development
• Figure 3 : Market Dynamics of AI in Cancer Market
• Figure 4 : Emerging Technologies in AI in Cancer Market
• Figure 5 : Global Market Shares of AI in Cancer, by Cancer Type, 2023
• Figure 6 : Global Market Shares of AI in Cancer, by Application, 2023
• Figure 7 : Application of AI in Cancer Diagnosis
• Figure 8 : Global Market for AI in Cancer Diagnosis, 2021-2029
• Figure 9 : Global Market for AI in Cancer Drug Discovery and Development, 2021-2029
• Figure 10 : Global Market for AI in Cancer Therapy, 2021-2029
• Figure 11 : Global Market for AI in Cancer Screening, 2021-2029
• Figure 12 : Global Market for AI in Other Applications, 2021-2029
• Figure 13 : Global Market Shares of AI in Cancer, by End User, 2023
• Figure 14 : Global Market for AI in Cancer for Hospitals, 2021-2029
• Figure 15 : Global Market for AI in Cancer for Diagnostic Centers, 2021-2029
• Figure 16 : Global Market for AI in Cancer for Pharmaceutical Companies, 2021-2029
• Figure 17 : Global Market for AI in Cancer for Research Institutions, 2021-2029
• Figure 18 : Global Market Shares of AI in Cancer, by Region, 2023
• Figure 19 : Global Market for AI in Cancer, by Region, 2021-2029
• Figure 20 : North American Market Shares of AI in Cancer, by Country, 2023
• Figure 21 : U.S. Market for AI in Cancer, 2021-2029
• Figure 22 : Canadian Market for AI in Cancer, 2021-2029
• Figure 23 : Mexican Market for AI in Cancer, 2021-2029
• Figure 24 : European Market Shares of AI in Cancer, by Country, 2023
• Figure 25 : German Market for AI in Cancer, 2021-2029
• Figure 26 : French Market for AI in Cancer, 2021-2029
• Figure 27 : Italian Market for AI in Cancer, 2021-2029
• Figure 28 : Spanish Market for AI in Cancer, 2021-2029
• Figure 29 : U.K. Market for AI in Cancer, 2021-2029
• Figure 30 : Rest of European Market for AI in Cancer, 2021-2029
• Figure 31 : Asia-Pacific Market Shares of AI in Cancer, by Country, 2023
• Figure 32 : Chinese Market for AI in Cancer, 2021-2029
• Figure 33 : Japanese Market for AI in Cancer, 2021-2029
• Figure 34 : Indian Market for AI in Cancer, 2021-2029
• Figure 35 : Australian Market for AI in Cancer, 2021-2029
• Figure 36 : South Korean Market for AI in Cancer, 2021-2029
• Figure 37 : Rest of Asia-Pacific Market for AI in Cancer, 2021-2029
• Figure 38 : Snapshot of the ESG Pillars
• Figure 39 : Advantages of ESG for Companies
• Figure 40 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
• Figure 41 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
• Figure 42 : iCAD Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 43 : iCAD Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 44 : Lunit Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 45 : Lunit Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 46 : Median Technologies: Revenue Share, by Country/Region, FY 2023
• Figure 47 : NVIDIA Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 48 : NVIDIA Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 49 : Quest Diagnostics Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 50 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
• Figure 51 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

The North American market for AI in cancer is estimated to increase from $995.6 million in 2024 to reach $2.7 billion by 2029, at a CAGR of 21.6% from 2024 through 2029.

The Asia-Pacific market for AI in cancer is estimated to increase from $476.5 million in 2024 to reach $1.5 billion by 2029, at a CAGR of 26.2% from 2024 through 2029.

Report Scope:

The report highlights AI technology's current and future market potential for cancer applications. It provides a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into cancer screening, diagnosis, therapy, drug discovery and development and others. By cancer type, the market is segmented into breast, lung, prostate, gastrointestinal, brain and others. By end user, the market is segmented into hospitals, diagnostic centers, pharmaceutical companies and research institutions. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

By geographical region, the market is segregated into North America, Europe, Asia Pacific and the Rest of the world. The North American region includes countries the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historic years, 2023 as the base year and 2029 as the forecast year.

Report Includes:

• 42 data tables and 44 additional tables
• An up-to-date overview of the global markets for artificial intelligence (AI) in cancer
• Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the size of the market for artificial intelligence (AI) in cancer and revenue growth prospects, accompanied by a market share analysis by type, application, end user and region
• Assessment of market dynamics such as drivers, restraints and opportunities
• Coverage of current and emerging applications of AI in cancer and information on theranostics and generative AI tools
• A discussion on ESG challenges and practices in the industry
• Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
• Company profiles of major players within the industry, including Siemens Healthineers, GE Healthcare, NVIDIA Corp., and Lunit Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Overview
• Current and Emerging Applications of AI in Cancer
• Diagnosis
• Therapy
• Screening and Early Detection
• Drug Discovery and Development

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• AI in Drug Discovery and Development
• Increasing Incidence of Cancer
• Market Restraints
• Data Collection and Privacy
• False Positives and Bias
• Market Opportunities
• AI-Enabled Hardware Products

Chapter 4 Emerging Technologies

• Introduction
• AI for Multi-Cancer Early Detection
• Theranostics and AI
• Generative AI Tools
• Federated Learning

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Brain Cancer
• Other Cancers
• Market Analysis by Application
• Diagnosis
• Drug Discovery and Development
• Therapy
• Cancer Screening
• Other Applications
• Market Analysis by End User
• Market Size and Forecast
• Hospitals
• Diagnostic Centers
• Pharmaceutical Companies
• Research Institutions
• Geographic Breakdown
• Market Analysis by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Overview
• Partnerships
• M&A Activities
• Investments and Funding
• Patent Analysis

Chapter 7 Sustainability in the AI in the Cancer Market

• Introduction
• Sustainability in AI in the Cancer Industry
• Understanding the ESG Data
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AZRA AI
• CONCERTAI
• GE HEALTHCARE
• ICAD INC.
• LUNIT INC.
• MEDIAN TECHNOLOGIES
• NVIDIA CORP.
• QUEST DIAGNOSTICS INC.
• SIEMENS HEALTHINEERS AG